| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |